WARNING: FG Alerts Nigerians Over Latest Fake Drugs

2 Min Read
Health minister, Prof Isaac Adewole

The federal government has alerted Nigerians on circulation of  two confirmed falsified versions of Quinine Sulphate  in  Cameroon  and  the  Democratic  Republic  of  the  Congo.

It explained that though there is no evidence of the falsified drugs in Nigeria.

The government urged members of the public to report to the nearest office of The National Agency for Food and Drug Administration (NAFDAC) if the drugs are spotted anywhere, including hospitals and pharmaceutical shops.

This was contained in a statement by Director of Press and Public Relations, Federal Ministry of Health, Mrs. Boade Akinola.

Akinola explained: “These  products, which were  initially  discovered  by  a  local  NGO,  failed the preliminary  field  screening  and  were submitted to  a  WHO pre-qualified  Quality Assurance  laboratory.

“Subsequent analysis showed that neither product contained any of the stated active pharmaceutical ingredients.

“If you are in possession of these products, please do not use them.

“If you have taken this falsified product or suffer an adverse effect following its uptake, please seek immediate advice from a qualified healthcare professional and report the incident to NAFDAC.”

The numbers to contact are: +234-8037881120; +234-8055o56727;

+234-8035902679.

“Details of the product are shown below

1) Product Name

Quinine Sulfate 300 mg

Number of Tablets per container

1000

Batch Number

10H05

Expiry Date

09/2018

Date of manufacture

09/2014

Manufacturer

Novadina Pharmaceutical Ltd, London, United Kingdom.

2) Product Name

Quinine Sulphate 300mg

Number of Tablets per container

100

Batch Number

F4387

Expiry Date

11/18

Date of manufacture

12/14

Manufacturer

CAD Pharm, India”

 

Share this Article
Leave a comment

Leave a Reply

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.